NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells

Saima Muzaffar, JY Jeremy, Gianni D Angelini, Nilima Shukla

Research output: Contribution to journalArticle (Academic Journal)peer-review

23 Citations (Scopus)

Abstract

The protective actions of prostacyclin (PGI(2) ) are mediated by cyclic AMP (cAMP) which is reduced by type 4 phosphodiesterases (PDE4) which hydrolyze cAMP. Superoxide (O2(-)) from NADPH oxidase (Nox) is associated with impaired PGI(2) bioactivity. The objective of this study, therefore, was to study the relationship between Nox and PDE4 expression in human umbilical vein endothelial cells (HUVECs). HUVECs were incubated with the thromboxane A(2) analog, U46619, 8-isoprostane F(2α) (8IP), or tumor necrosing factor alpha (TNFα) [±iloprost (a PGI(2) analog)] and the expression of PDE4A, B, C, and D and splice variants thereof assessed using Western blotting and qPCR and mRNA silencing of Nox4 and Nox5. Effects on cell replication and angiogenesis were also studied. U46619, 8IP, and TNFα increased the expression of Nox 4 and Nox 5 and all PDE4 isoforms as well as cell replication and tubule formation (index of angiogenesis), effects inhibited by mRNA silencing of Nox4 (but not Nox5) and iloprost and rolipram. These data demonstrate that upregulation of Nox4 leads to an upregulation of PDE4A, B, and D and increased hydrolysis of cAMP which in turn augments cell replication and angiogenesis. This mechanism may be central to vasculopathies associated with endothelial dysfunction since the PGI(2)-cAMP signaling axis plays a key role in mediating functions that include hemostasis and angiogenesis.
Translated title of the contributionNADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells
Original languageEnglish
Pages (from-to)1941 - 1950
Number of pages10
JournalJournal of Cellular Physiology
Volume227(5)
DOIs
Publication statusPublished - May 2012

Fingerprint Dive into the research topics of 'NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells'. Together they form a unique fingerprint.

Cite this